FKBP51 Recombinant Antibody

$Lane 1: Rat Kidney; Lane 2: Daudi Cells; Probed with FKBP5 (6G6) Monoclonal Antibody (bsm-54309R) at 1:500 overnight at 4\u00b0C followed by a conjugated secondary antibody for 60 minutes at 37\u00b0C.$

Lane 1: Rat Kidney; Lane 2: Daudi Cells; Probed with FKBP5 (6G6) Monoclonal Antibody (bsm-54309R) at 1:500 overnight at 4\u00b0C followed by a conjugated secondary antibody for 60 minutes at 37\u00b0C.

$Paraformaldehyde-fixed and paraffin-embedded Human Tonsil tissue incubated with FKBP5 (6G6) Monoclonal Antibody (bsm-54309R) at 1:100, overnight at 4\u00b0C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.$

Paraformaldehyde-fixed and paraffin-embedded Human Tonsil tissue incubated with FKBP5 (6G6) Monoclonal Antibody (bsm-54309R) at 1:100, overnight at 4\u00b0C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.

$Paraformaldehyde-fixed and paraffin-embedded Human Kidney tissue incubated with FKBP5 (6G6) Monoclonal Antibody (bsm-54309R) at 1:100, overnight at 4\u00b0C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.$

Paraformaldehyde-fixed and paraffin-embedded Human Kidney tissue incubated with FKBP5 (6G6) Monoclonal Antibody (bsm-54309R) at 1:100, overnight at 4\u00b0C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.

$Paraformaldehyde-fixed and paraffin-embedded Rat Lung tissue incubated with FKBP5 (6G6) Monoclonal Antibody (bsm-54309R) at 1:100, overnight at 4\u00b0C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.$

Paraformaldehyde-fixed and paraffin-embedded Rat Lung tissue incubated with FKBP5 (6G6) Monoclonal Antibody (bsm-54309R) at 1:100, overnight at 4\u00b0C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.

Flow cytometric analysis of Daudi cells with FKBP5 (6G6) Monoclonal Antibody (bsm-54309R) at a 1:100 dilution (red) compared with an unlabeled control (cells without incubation with primary antibody; black).

Applications

WB
IHC-P
IHC-F
IF
Flow-Cyt

Reactivity

Human
Rat

Overview
Catalog #	bsm-54309r
Product Name	FKBP51 Recombinant Antibody
Applications	WB, IHC-P, IHC-F, IF, Flow-Cyt
Reactivity	Human, Rat
Specifications
Conjugation	Unconjugated
Host	Rabbit
Source	Synthetic peptide corresponding to the C-terminus of human FKBP51
Clonality	Recombinant
Isotype	IgG
Concentration	1ug/ul
Purification	Purified by Protein A.
Storage Buffer	0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
Storage Condition	Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
Target
Gene ID	2289
Swiss Prot	Q13451
Subcellular location	Cytoplasm, Nucleus
Synonyms	Peptidyl-prolyl cis-trans isomerase FKBP5; 51 kDa FK506-binding protein; 54 kDa progesterone receptor-associated immunophilin; Androgen-regulated protein 6; FF1 antigen; FK506-binding protein 5; FKBP54; HSP90-binding immunophilin; Rotamase; PPIase FKBP5; 51 kDa FKBP; FKBP-51; FKBP-5; p54; FKBP5; AIG6; FKBP51
Background	Immunophilin protein with PPIase and co-chaperone activities. Component of unligated steroid receptors heterocomplexes through interaction with heat-shock protein 90 (HSP90). Plays a role in the intracellular trafficking of heterooligomeric forms of steroid hormone receptors maintaining the complex into the cytoplasm when unliganded.
Application Dilution
WB	1:300-5000
IHC-P	1:200-400
IHC-F	1:100-500
IF
Flow-Cyt	1ug/Test